Echo-AVCS: Drawing AI-powered clues from heart scans to confirm severe aortic stenosis
Official title: Derivation and Validation of the Aortic Valve Echocardiographic Calcium Score to Confirm Severe Aortic Stenosis: the Echo-AVCS Study
Run by Azienda Ospedaliera "Sant'Andrea" · NCT07620925 · Data updated 2026-11-12
This study tests an AI-based echocardiography score to help confirm severe aortic stenosis in adults who are also getting CT calcium scoring.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Azienda Ospedaliera "Sant'Andrea" Academic / other |
| Drugs / interventions | radiation |
| Locations | 5 sites (Bologna and 4 other locations) |
| Status | Recruiting |
| Started | March 1, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | June 4, 2026 |
| Trial ID | NCT07620925 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults, 18 years or older, with a clinical indication for standard echocardiography and a cardiac CT calcium score within three months, who can provide informed consent.
✕Probably not a fit
Patients with poor image quality, prior valve replacements, or congenital heart defects other than bicuspid aortic valve may not benefit from the AI-based scoring approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, multicenter observational study designed to derive and validate an AI-driven echocardiographic aortic valve calcium score (Echo-AVCS) for confirming severe aortic stenosis. Participants are adults undergoing standard transthoracic echocardiography and a cardiac CT calcium score within a three-month window. Standardized echocardiographic images will be centrally analyzed using AI-based image segmentation and machine learning to correlate with CT calcium scoring and diagnostic certainty, potentially reducing reliance on CT and radiation. The study addresses cases where echocardiographic measures of stenosis are discordant or low-flow, offering a data-driven approach to improve diagnostic confidence. Interventions involve routine echocardiography and cardiac CT imaging; no experimental treatments are given.
Why it matters
Potential benefit: If successful, Echo-AVCS could provide a more accurate, non-invasive way to confirm severe aortic stenosis using AI-aided echocardiography, potentially reducing additional imaging and radiation.
How similar studies have gone: Previous work combining imaging AI with calcium scoring in cardiology has shown promise, but this specific Echo-AVCS approach is novel in deriving a non-invasive score for AS confirmation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years old * Clinical indication for standard transthoracic echocardiography. * Clinical indication for cardiac CT with available calcium score. * 3-month time interval between transthoracic echocardiography and cardiac CT. * Able to give informed consent. Exclusion Criteria: * Patients with inadequate transthoracic echocardiographic images. * Poor quality cardiac CT, inadequate for standard calcium score assessment. * Patients with known prior stents and/or coronary artery bypass grafts. * Patients with known previous percutaneous or surgical aortic valve replacement. * Patients with active or a history of endocarditis. * Patients with congenital heart defects (other than isolated bicuspid aortic valve).
Where it's running
-
University of Bologna
Bologna, Italy Recruiting -
Centro Cardiologico Monzino
Milan, Italy Recruiting -
IRCCS Galeazzi-Sant'Amborgio
Milan, Italy Recruiting -
Sant'Andrea University Hospital
Roma, Italy Recruiting -
Politecnico di Milano
Milan, Italy Active not recruiting
Study contacts
- Study coordinator: Emanuele Barbato, Full Professor
- Email: emanuele.barbato@uniroma1.it
- Phone: 0633778763
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise and nutrition support before and after TAVI for older adults with aortic stenosis
This trial tests whether a personalized exercise program plus protein and iron supplements before and after a transcatheter valve replacement can help older adults with aortic stenosis recover better than standard care.
-
Common femoral vein-to-artery diameter ratio to detect elevated LVEDP
Researchers test whether the ratio of the common femoral vein to artery diameters, measured by ultrasound, can flag elevated LV end-diastolic pressure in patients having coronary angiography.
-
Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI
This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.
-
See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease
In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.
-
Association Between Aortic Valve Area Changes and Pulmonary Congestion After TAVI
This study tests whether improvements in aortic valve opening after TAVI relate to reductions in lung congestion measured by ultrasound in adults with severe aortic stenosis.
-
Systematic 14-day ambulatory heart monitoring after TAVI
After TAVI, patients with certain heart conduction abnormalities will try 14 days of wearable ECG monitoring to see if it lowers the chances of sudden death, symptomatic heart rhythm problems, or stroke within a year compared to standard follow-up.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.